Gary Brian Finka

Title: Gary Brian Finka: Innovator in Recombinant Protein Production

Introduction

Gary Brian Finka is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 2 patents, Finka's work has the potential to enhance various biotechnological processes.

Latest Patents

Finka's latest patents include innovative methods for producing recombinant proteins. One patent describes a method that involves adding Polyethyleneimine (PEI) during cell culture. This addition serves as a fermentation enhancer, which can reduce the viscosity of the cell culture, increase the extracellular concentration of the recombinant protein, and shorten the duration of cell culture before harvest or protein recovery. Another patent focuses on a recombinant signal sequence derived from a specific source. This invention also includes a fusion protein that comprises the signal sequence and a recombinant protein, providing methods for controlling fermentation viscosity and basal expression of the recombinant protein.

Career Highlights

Throughout his career, Gary Brian Finka has worked with prominent companies in the biotechnology sector. He has been associated with Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has contributed to his expertise in the field.

Collaborations

Finka has collaborated with notable professionals in his field, including Michael Hoare and Mark Uden. These collaborations have likely enriched his research and development efforts.

Conclusion

Gary Brian Finka's contributions to recombinant protein production demonstrate his innovative spirit and commitment to advancing biotechnology. His patents reflect a deep understanding of fermentation processes and protein production, which can have a lasting impact on the industry.